Yaws
0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
New World MedicalCA - Rancho Cucamonga
3 programsAzithromycinPHASE_31 trial
AzithromycinPHASE_31 trial
R1-Total community treatment with azithromycinPHASE_41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
New World MedicalR1-Total community treatment with azithromycin
New World MedicalAzithromycin
New World MedicalAzithromycin
Clinical Trials (3)
Total enrollment: 72,583 patients across 3 trials
Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication
Start: Apr 2018Est. completion: Apr 202056,000 patients
Phase 4Completed
Comparison of Two Different Doses of Azithromycin for Treatment of Yaws
Start: Jun 2015Est. completion: Dec 2016583 patients
Phase 3Completed
Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea
Start: Mar 2013Est. completion: May 201716,000 patients
Phase 3Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.